James H. Erlinger's most recent trade in Veracyte Inc was a trade of 15,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 26, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Veracyte Inc | James H. Erlinger | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | James H. Erlinger | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 7,500 | 7,500 (0%) | 0% | 0 | Common Stock |